Fiduciary Trust CO Novartis Ag Transaction History

Fiduciary Trust CO

  • $7.39 Billion
  • Q1 2025

A detailed history of Fiduciary Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Fiduciary Trust CO holds 59,423 shares of NVS stock, worth $6.88 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
59,423
Previous 49,558 19.91%
Holding current value
$6.88 Million
Previous $4.82 Million 37.37%
% of portfolio
0.09%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$97.14 - $115.57 $958,286 - $1.14 Million
9,865 Added 19.91%
59,423 $6.62 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $38,615 - $46,754
-399 Reduced 0.8%
49,558 $4.82 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $63,678 - $72,534
600 Added 1.22%
49,957 $5.75 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $266,323 - $308,903
-2,877 Reduced 5.51%
49,357 $5.25 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $9,145 - $10,413
-96 Reduced 0.18%
52,234 $5.05 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $64,404 - $70,874
-698 Reduced 1.32%
52,330 $5.28 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $51,627 - $57,295
-545 Reduced 1.02%
53,028 $5.4 Million
Q2 2023

Aug 01, 2023
SELL
$92.52 - $104.91 $162,002 - $183,697
-1,751 Reduced 3.16%
53,573 $5.41 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $139,412 - $161,675
-1,742 Reduced 3.05%
55,324 $5.09 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $99,650 - $122,033
-1,319 Reduced 2.26%
57,066 $5.18 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $42,453 - $49,650
569 Added 0.98%
58,385 $4.44 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $70,052 - $81,562
-870 Reduced 1.48%
57,816 $4.89 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $278,222 - $314,723
-3,473 Reduced 5.59%
58,686 $5.15 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $419,540 - $463,916
-5,264 Reduced 7.81%
62,159 $5.44 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $754,093 - $877,285
-9,221 Reduced 12.03%
67,423 $5.51 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $1.27 Million - $1.4 Million
-14,884 Reduced 16.26%
76,644 $6.99 Million
Q1 2021

May 19, 2021
SELL
$83.5 - $98.47 $146,960 - $173,307
-1,760 Reduced 1.89%
91,528 $7.82 Million
Q4 2020

Jan 26, 2021
SELL
$78.07 - $94.43 $714,730 - $864,506
-9,155 Reduced 8.94%
93,288 $8.81 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $119,842 - $132,769
-1,459 Reduced 1.4%
102,443 $8.91 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $124,874 - $140,567
-1,543 Reduced 1.46%
103,902 $9.08 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $79,433 - $111,287
-1,124 Reduced 1.05%
105,445 $8.69 Million
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $268,654 - $303,753
-3,185 Reduced 2.9%
106,569 $10.1 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $280,742 - $309,361
3,282 Added 3.08%
109,754 $9.54 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $125,390 - $154,326
1,663 Added 1.59%
106,472 $9.72 Million
Q1 2019

May 07, 2019
SELL
$75.32 - $86.15 $295,329 - $337,794
-3,921 Reduced 3.61%
104,809 $10.1 Million
Q4 2018

Jan 29, 2019
SELL
$73.66 - $82.02 $29,243 - $32,561
-397 Reduced 0.36%
108,730 $9.33 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $176,386 - $204,028
-2,635 Reduced 2.36%
109,127 $9.4 Million
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $804,234 - $908,930
-12,390 Reduced 9.98%
111,762 $8.44 Million
Q1 2018

May 08, 2018
BUY
$70.39 - $84.15 $212,296 - $253,796
3,016 Added 2.49%
124,152 $10 Million
Q4 2017

Jan 29, 2018
SELL
$72.33 - $77.64 $111,605 - $119,798
-1,543 Reduced 1.26%
121,136 $10.2 Million
Q3 2017

Nov 02, 2017
BUY
$74.14 - $77.27 $9.1 Million - $9.48 Million
122,679
122,679 $10.5 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email